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ABSTRACT 
 
 
Cassie Almond: Adherence and Compliance to a Community-Based Exercise 
Intervention and the Effect on VO2peak in Breast Cancer Survivors  
 (Under the direction of Dr. Claudio Battaglini) 
 
 
Purpose As more breast cancer patients are surviving longer after diagnosis, there is a 
growing population of survivors dealing with long-term negative side effects of treatment. 
Exercise has been widely supported as an effective measure in mitigating these side effects. 
However, reporting of all exercise intervention components remains incomplete limiting 
our understanding of the effectiveness of specific exercise prescription components on 
primary outcomes and limits study replication. The purpose of this study was to evaluate 
the exercise adherence and compliance of breast cancer patients to a 16-week community-
based, supervised, progressive, aerobic and resistance exercise training intervention and to 
determine the effects on change in VO2peak. Methods Early stage breast cancer patients 
within one year of completing primary treatments were enrolled in a 16-week community-
based exercise intervention. Participants attended 3, 1-hour small group exercise sessions 
per week. Over the course of the intervention, aerobic training increased intensities to 12-
14 RPE, resistance training increased intensities to 14-15 RPE, and durations increasing to 
~30min. Adherence reflects attendance: days attended vs. days prescribed. Compliance 
reflects the degree to which participants completed the exercise prescription; reaching 
prescribed intensities for prescribed durations. Results Patients had an average aerobic and 
resistance adherence of 72.5%. Aerobic compliance of 23.6 days (49.1%) and resistance 
compliance of 12.5 days (26.0%). A paired samples t-test revealed a non-significant 
increase in VO2peak (+0.9 mL/kg/min, p=0.178) following the intervention. Conclusion 
VO2peak improvements were not statistically significant. However, VO2peak was maintained 
following the intervention suggesting that with even low compliance maintenance of 
cardiorespiratory fitness is possible.  
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Chapter I 
 
 
 
INTRODUCTION 
 
Among women, breast cancer is the most common form of cancer diagnosed with 
1 in 8 expected to be diagnosed during their lifetime1, 2. Due to increased awareness, earlier 
detection, and improved targeted therapies, mortality rates are declining and more patients 
are surviving longer after diagnosis4. As a result, there is a growing population of breast 
cancer survivors dealing with lasting side effects of treatment. Such side effects include: 
fatigue, decreased aerobic capacity and muscle strength, increased weight gain, and an 
overall reduction in quality of life5. Exercise has widely been supported as an effective 
measure in mitigating these adverse effects. Additional studies have further explored 
modifications to exercise prescription components in relation to the FITT (Frequency, 
Intensity, Time, and Time) Principle in an effort to maximize the reduction of negative side 
effects9-12.  
While the evidence supporting the benefits of exercise in breast cancer survivors 
continues to grow, reporting of all components of the exercise prescription and patient 
adherence and compliance to all aspects of the exercise intervention remains incomplete14. 
Due to incomplete reporting, determining the effectiveness of specific exercise prescription 
components is complicated and study replication is limited14. Therefore, it is critical that 
studies clearly report exercise prescriptions as they apply to the FITT principle and 
participants’ degree of adherence and compliance to all components.  
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Statement of the Purpose: 
The purpose of this study was to evaluate the exercise adherence and compliance 
of breast cancer patients to a 16-week community-based, supervised, progressive, aerobic 
and resistance exercise training intervention and to determine the effects on change in 
VO2peak. 
 
We hypothesized that breast cancer survivors would adhere (attending ≥80% of 
sessions) and comply (completing ≥80% of session as prescribed) to the exercise 
prescription. Additionally, we hypothesized that a compliance ≥80% of the sessions would 
impact changes in aerobic capacity following 16 weeks of training. We hypothesized that 
there would be a significant difference in Delta VO2peak between compliant (compliance 
≥80% of sessions) and non-compliant (compliance <80% of sessions) cancer patients who 
participated in the 16-week community-based exercise program. 
 
Research Questions: 
R1. Will breast cancer patients be adherent to the aerobic exercise prescription? 
R2. Will breast cancer patients be adherent to the resistance exercise prescription? 
R3. Do breast cancer patients comply to the aerobic exercise prescription? 
R4. Do breast cancer patients comply to the resistance exercise prescription? 
R5. Will VO2peak differ between pre and post testing for breast cancer patients who comply 
to both aerobic and resistance exercise portions of the intervention? 
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R6. Will Delta VO2peak differ between breast cancer patients who comply and breast cancer 
patients who do not comply to both aerobic and resistance exercise portions of the 
intervention? 
 
Hypotheses: 
H1.  Breast cancer patients will be adherent to the aerobic exercise prescription. 
H2. Breast cancer patients will be adherent to the resistance exercise prescription.  
H3. Breast cancer patients will comply with the aerobic exercise prescription. 
H4. Breast cancer patients will comply with the resistance exercise prescription. 
H5. VO2peak will differ between pre and post testing for breast cancer patients who comply 
to both aerobic and resistance exercise portions of the intervention.  
H6. Delta VO2peak will differ between breast cancer patients who comply and breast cancer 
patients who do not comply to both aerobic and resistance exercise portions of the 
intervention.  
 
Operational Definitions: 
 Get REAL & HEEL Breast Cancer Community-Based Exercise Program: 16-week 
supervised, combined, progressive aerobic and resistance exercise training program 
for breast cancer survivors. Group format, approximately 8-10 participants per 
session with 3 sessions per week, approximately 1 hour per session. Progression 
goals: by week 8, 30 minutes of aerobic exercise and 30 minutes of strength training 
at each session. 
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  Aerobic Exercise Training Adherence: total days of completed aerobic training 
divided by total days of aerobic prescription multiplied by 100%. Participants are 
considered adherent if they reach ≥80% of prescribed days. 
 Resistance Exercise Training Adherence: total days of completed resistance 
training divided by total days of resistance prescription multiplied by 100%. 
Participants are considered adherent if they reach ≥80% of prescribed days. 
 Aerobic Exercise Training Compliance: degree to which the participant completes 
the prescribed duration (time) and intensity (RPE) of the aerobic training 
prescription. Patients are considered compliant if 80% of the prescribed duration 
(≥24 out of 30min) is completed within the prescribed intensity for ≥80% of total 
days prescribed (≥39 days).  
 Resistance Exercise Training Compliance: degree to which the participant 
completes the prescribed duration (time) and intensity (RPE) of the resistance 
training prescription. Patients are considered compliant if they complete ≥80% of 
prescribed total sets/reps at an average intensity within the prescribed intensity 
range for ≥80% of total days (compliant ≥39 days). 
 
Delimitations:  
 Participants for the study were 24 females between the ages of 27 and 77 years old 
diagnosed with early stage breast cancer who had completed their major treatments 
within one year. 
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 Participants were required to be free of any health condition precluding safe 
participation in exercise testing or training and cleared by their oncologist to 
participate in the study.  
 
Assumptions: 
 The different early-stage cancer diagnoses (i.e. Stage I, II, III) would not interfere 
with the exercise training responses of those who adhere to the minimum defined 
accepted levels in this study.  
 The various forms of treatments subjects underwent prior to the study would not 
interfere with the subject’s ability to adhere to or comply with the exercise training 
prescription. 
 
Limitations: 
 The different cancer treatments may influence adherence, compliance, and 
response to the exercise training program. 
 Quantification of the resistance training intensity; The resistance training load for 
the overall study sample cannot be quantified due to the multimodal approach (body 
weight, resistance bands, free weights, etc.) of resistance equipment available/used 
per patient to reach the prescribed intensity. 
 Intensity as primarily measured/monitored by RPE may not reflect that 
measured/monitored by HRR but feasibility precludes the consistent use of HRR in 
the community-based setting. 
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Significance of the Study 
 
Adherence and compliance to exercise interventions are important factors when 
evaluating study outcomes and replication but are frequently ill-defined, poorly reported, 
or missing in exercise oncology literature. This study was designed to define, quantify, and 
evaluate the adherence and compliance of breast cancer patients who participated in a 
community-based exercise program as a whole, by aerobic, and by resistance training 
components. The knowledge gained in this study enhances our understanding of patient 
compliance in a community-based program and the impact of that compliance on change 
in aerobic capacity. This provides opportunity to improve future research study design and 
potentially optimize the training design/operation of a community-based program. 
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Chapter II 
 
 
 
REVIEW OF LITERATURE 
 
Breast cancer is the most common form of cancer diagnosed among women with 
approximately 1/8 of all women expected to be diagnosed during their lifetime1, 2. In 2018, 
an estimated 266,120 women will be diagnosed3. Behind lung and bronchus cancer, breast 
cancer is the second leading cause of cancer deaths among women and estimates indicate 
40,920 women will die from breast cancer in 20181, 2. For over a decade, the rates of new 
breast cancer diagnoses have remained relatively stable, only rising an average of 0.3% 
each year2. In contrast, mortality rates have been declining an average of 1.8% each year 
due to increased awareness, earlier detection, and improved targeted therapy2, 4. As a result, 
there is a growing population of breast cancer survivors living longer after diagnosis and 
dealing with lasting side effects that require long-term care.   
While women diagnosed with breast cancer vary in race, ethnicity, and age, several 
negative side effects associated with breast cancer treatment are shared. Common side 
effects experienced include fatigue, decreased levels of muscular strength, decreased 
aerobic capacity, increased weight gain, and reduced quality of life5. Previous research has 
widely supported the effectiveness of exercise during or after treatment to minimize 
adverse effects. Aerobic exercise has been shown to be effective in improving aerobic 
capacity and body composition among other outcomes5. Resistance training is associated 
with increased muscular strength and improved chemotherapy completion rates6. 
 14  
Additionally, regular physical activity has been shown to improve self-esteem and physical 
functioning, which are both associated with quality of life5. 
A few studies have further explored the components of exercise prescriptions in 
relation to the FITT (Frequency, Intensity, Time, and Type) Principle8-12. In an effort to 
maximize the reduction of unfavorable effects related to treatment, studies have examined 
modifications of each training component and the impact on patient physiological and 
psychosocial outcomes. Such modifications include: high versus low frequency, intensity, 
and duration9-12. Different types of exercise, such as aerobic and/or resistance training have 
been compared8, 12. 
The American College of Sports Medicine recommends for breast cancer survivors 
weekly activity of 150 minutes of moderate-intensity exercise or 75 minutes of vigorous-
intensity exercise or an equivalent combination7. Strength training is to be performed two 
to three sessions per week targeting major muscle groups at a slow progression rate7.  
Currently, the average frequency of training for exercise prescriptions is 3 training sessions 
per week with a range of 2-5 sessions per week8. The majority of prescriptions are a 
combination of aerobic and resistance training8. Each training session is on average 46 
minutes8.  
In researching the effects of exercise prescription intensity, level of intensity (high 
versus low), interval versus continuous intensity, and load of training have been examined9-
11, 16. The measure used to determine intensity in aerobic interventions varies between 
studies. In a study examining high vs. low aerobic intensity, intensity was determined using 
VO2peak
9. In contrast, a study examining interval versus continuous intensity used a 
combination of the Borg Scale and maximal workload (as estimated by the Steep Ramp 
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Test) to determine intensity11. Supervised, moderate- to high-intensity exercise 
prescriptions have been found to be effective in minimizing fatigue, symptom burden, 
declines in cardiorespiratory fitness and muscle strength than low intensity9. Home-based, 
low intensity exercise prescriptions, can produce significant, positive effects but generally 
to a lesser extent than moderate or high intensity9. Additionally, high intensity exercise was 
found to be associated with more sustainable cardiorespiratory benefits post intervention 
than low intensity exercise10. Both interval high intensity and continuous moderate 
intensity training prescriptions are associated with an increase in aerobic capacity and a 
decrease in resting heart rate11. High intensity interval training is also associated with a 
decrease in body weight and an increase in lower body strength11. High-load strength 
training is associated with improved total lean body mass in the extremities and physical 
function16. These changes are beneficial in reducing the negative side effects associated 
with cancer treatment.  
Initial studies of exercise type examined effects of aerobic exercise and resistance 
exercise separately. Both were found to significantly improve self-esteem, physical fitness, 
and body composition. In addition, aerobic exercise was found to maintain body fat levels 
and blunt a decline in maximal oxygen consumption preserving aerobic fitness. Resistance 
exercise was found to additionally improve muscular fitness strength and lean body mass8. 
Further research compared high dose, aerobic-only exercise to a combination of aerobic 
and resistance exercise12.  Higher dose aerobic-only exercise was found to mitigate some 
of the negative impacts of chemotherapy on aerobic fitness, physical functioning, bodily 
pain, fatigue, and endocrine symptoms. Combined exercise partially curbed endocrine 
symptoms and improved muscular fitness. These results are suggestive of an exercise type 
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effect12. Furthermore, previous research on exercise dosage suggests a direct correlation 
between dosage and response. Higher doses of aerobic exercise were found to be superior 
to lower doses in curbing negative impacts on aerobic fitness, patient-reported physical 
functioning, bodily pain, fatigue, and endocrine symptoms. A higher dosage was also found 
to partially blunt a substantial decline in maximal oxygen uptake. These results are thus 
suggestive of a dose-response effect for aerobic exercise12.  Taken broadly, these 
relationships support the potential for exercise to be tailored by type and time to improve 
patient outcomes, and existing research has explored this possibility. 
Exercise prescriptions for cancer patients have progressed from examining aerobic 
only exercise to more complex prescriptions altering dosage, type, and intensity of 
exercise8. While exercise prescriptions have become more complex, the reporting of all 
components of the exercise prescription and patient adherence to all components remain 
incomplete. From 1990-2017, no studies have reported all components of the exercise 
prescription or patient adherence and compliance to the prescribed exercise interventions13, 
14. The lack of complete reporting of the exact prescription in addition to patient adherence 
and compliance, results in an inability to determine which features of an exercise 
prescription are more or less effective in mitigating adverse effects, impacting study 
outcomes, and complicating study replication. It is imperative that future studies clearly 
define and report exercise prescriptions as they apply to the FITT principle and to describe 
and report participant adherence and compliance to training interventions14. 
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Chapter III 
 
 
 
METHODOLOGY 
 
 
Study Design 
 This is a retrospective study using data collected from the UNC Get REAL & Heel 
Research Study (UNC IRB 16-3284, LCCC1630). In the referenced study, women with 
recently treated, early-stage breast cancer completed physiological testing before and after 
16-weeks of exercise training at UNC Get REAL & Heel, a community-based exercise 
program for cancer survivors. Physiological outcome data including aerobic capacity 
(VO2peak) and exercise logs documenting patient participation in the exercise training were 
used for the analyses of study outcomes. 
 
Participants  
Twenty-four women with early stage breast cancer, who were within one year of 
completing primary breast cancer treatments (surgery, radiation therapy, and 
chemotherapy) were enrolled in a 16-week exercise intervention (Get REAL & HEEL 
(GR&H) Breast Cancer Exercise Rehabilitation Program). Participants were identified 
through review of daily clinic schedules for patients seen at the North Carolina Cancer 
Hospital and also referred to GR&H from other medical institutions around the North 
Carolina Research Triangle Area, provided participants met eligibility criteria for 
participation in the study. All participants were cleared to participate by their treating 
oncologists.  Participants were excluded if under the age of 21, lack evidence of cancer 
diagnosis or completion of surgery, radiation and/or chemotherapy treatment, are ≥1 year 
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from completing primary cancer therapies, or have previously completed the GR&H 
exercise program.  
 
Instrumentation 
 Cardiorespiratory Exercise Test (CPET): assesses cardiorespiratory function and 
was performed on an electronically braked cycle ergometer (Lode, Groningen, The 
Netherlands). Outcomes include total exercise time, max HR, RPE final stage, peak 
wattage, and VO2peak.VO2peak assessed using a continuous incremental ramp protocol 
following standard ACSM exercise testing guidelines. Breath by breath metabolic analysis 
using a Parvo Medics TrueMax® 2300 Metabolic system (Parvo Medics, Salt Lake City, 
UT, USA) was used for the assessment of VO2peak. Prior to testing, participants were 
cleared via completion of a Physical Activity Readiness Questionnaire (PAR-Q), and a 12-
lead resting electrocardiogram (ECG; which was sent to a study team physician for 
approval).  
 GRH Exercise Logs: record information regarding time, mode (aerobic or 
resistance), amount (load, sets, and reps), and intensity (RPE) of exercise completed per 
session. 
 
Protocol Overview  
The GR&H exercise intervention is a 16-week supervised, individualized exercise 
program, including 3 sessions per week, approximately 1 hour per session. The sessions 
are small group format with approximately 8-10 study participants. The exercise 
prescription is a combination of progressive aerobic and resistance exercise training. 
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Before, during, and after each exercise session HR are recorded. Additionally, the number 
of sets/reps, intensity, RPE, and duration of aerobic exercise completed are recorded.   
Following securement of written informed consent from study participants, patients 
were given a Physical Activity Readiness Questionnaire (PAR-Q) and completed a 
cardiopulmonary exercise testing (CPET) assessment. Measurements were taken at 
baseline and at the end of the 16-week intervention. The cardiopulmonary exercise test 
(CPET) started with study participants sitting quietly on the cycle ergometer for 3-minutes 
while their resting metabolic data was collected. The first stage of the test begun as a 2-
minute unloaded warm up at 0 watts followed by a 3-minute loaded warm up phase of 20 
watts. Following the warm up stages, the wattage/workload increased continuously by 15 
watts/min until test termination. HR and RPE (6-20) were continually monitored and 
recorded throughout the testing. Termination of the test was determined by subject reaching 
volitional exhaustion and signaling to stop the test, VO2 plateau or decrease with increase 
in exercise intensity, or if an abnormal subject response to the test is observed and therefore 
the research team will terminated the test. CPET study outcomes included total exercise 
time, max HR, RPE final stage, peak wattage, and VO2peak.  
 
Exercise Intervention 
Modes of aerobic exercise options included: cycling, walking, jogging, elliptical or 
seated stepper. For the first 2 weeks, aerobic exercise volume and intensities begun at 10-
15 minutes at low intensity with a corresponding RPE (Rate of Perceived Exertion) 
between 8-11 on the Borg Rating of Perceived Exertion Scale with corresponding heart 
rates of approximately 50%-60% of heart rate reserve (HRR). The goal was for the 
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participant to achieve 30 minutes of moderate intensity aerobic exercise by week 8 with a 
respective RPE between 12-14 and heart rates of 65%-75% HRR. RPE was the primary 
gauge for intensity with heart rates used as a secondary measure. Fluctuations in heart rate 
response to exercise in clinical populations like breast cancer survivors have been 
documented15. For community-based settings like GR&H, the feasibility of prescribing 
exercise based on heart rate response is less feasible and therefore RPE has been used as 
the primary gauge for intensity over the history of the program’s existence.  
The resistance training prescription will included 4-6 resistance exercises per 
session targeting large muscle groups in the upper body, lower body, and core to improve 
strength, balance, and functionality. Possible exercises included: lateral raises wall push-
ups, rows, squats, bridge, plank, reverse sit up, shrugs, tandem stance, and lateral pulldown. 
Each session lasted approximately 30 minutes. In weeks 1-5, two sets of each exercise were 
performed for 10-15 repetitions with intensity progressing from light to moderate (RPE 7-
13). After week 5, attempts were made to increase the intensity from moderate to high 
(RPE 14-15) for 2 sets of 10 repetitions of each exercise. Training progressed slowly, 
starting the first two weeks of training with 1 set of resistance exercises using no weight or 
very light weight with 15 repetitions, then in weeks 3-5 increasing up to 2 sets.  
 
Quantification of Intervention Adherence/Compliance  
The adherence and compliance to prescribed aerobic and resistance training at 
GR&H are represented as a percentage and days meeting set criteria, respectively. For 
adherence to aerobic exercise, total days aerobic exercise completed were divided by total 
days aerobic exercise prescribed, 48, for 3 sessions for 16 weeks, and multiplied by 100. 
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Patients were considered adherent with an aerobic adherence ≥80%. For adherence to 
resistance training, total days resistance training completed were divided by total days 
resistance training prescribed, 48, for 3 sessions for 16 weeks, and multiplied by 100. 
Patients were considered adherent with a resistance adherence ≥80%.  
For compliance to aerobic exercise, minutes of aerobic exercise completed per day 
at a prescribed intensity were divided by the total minutes prescribed at particular intensity, 
then multiplied by 100. Completing ≥80% of the prescribed duration at the prescribed 
intensity dictates one day of compliance.  Patients were considered fully compliant with 
the aerobic portion if they complete ≥80% duration at prescribed intensity criteria for ≥80% 
of total days prescribed (compliant ≥39 days). For compliance to resistance training, the 
sum number of sets completed were multiplied by the number of completed reps, which 
were then multiplied by the number of completed exercises for a total completed volume. 
This value will be divided by the sum number of prescribed sets multiplied by number of 
prescribed reps, multiplied by the prescribed number of exercises for total possible volume. 
The resulting value is then multiplied by 100. Completing ≥80% of the prescribed 
resistance prescription dictates one day of compliance. Patients are considered fully 
compliant with the resistance portion if they complete ≥80% prescribed resistance 
prescription for ≥80% of total days prescribed (compliant ≥39 days).  
 
Statistical Analysis  
All data was gathered and entered into an electronic database for analysis. The 
alpha level was set a priori at 0.05 for all analyses. All statistical analyses were performed 
using SPSS (SPSS, Inc.; Chicago, IL, USA). Descriptive statistics are presented in the form 
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of means and standard deviations to describe overall adherence and compliance of patients 
to the intervention. A paired t-test was used to evaluate the change in VO2peak from pre to 
post testing in the group of women who were deemed compliant to intervention protocol. 
An independent t-test was used to evaluate the change in VO2peak between the compliant 
group and the non-compliant group.  
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Chapter IV 
 
 
 
RESULTS 
The purpose of this study was to evaluate breast cancer patients’ adherence and 
compliance to prescribed aerobic and resistance training in a 16-week community-based, 
supervised, and progressive exercise program. Additionally, changes in VO2peak among 
compliant patients, and changes in VO2peak between compliant and non-compliant patients 
were also evaluated.  
 
Participants 
 Twenty-four women (aged 55±13 years) diagnosed with early stage breast cancer, 
who were within one year of completing primary breast cancer treatments (surgery, 
radiation therapy, and chemotherapy) were recruited and completed the 16-week exercise 
intervention study protocol using the UNC Get REAL & HEEL (GR&H) exercise program. 
The Participants’ characteristics are presented in Table 1. 
Table 1. Study Sample Descriptive Statistics 
Characteristic (n=24) Baseline 
Age (years) 55.3 ± 12.8 
Height (cm) 166.6 ± 7.6 
Weight (kg) 75.9 ± 13.1 
Menopausal Status 66% Postmenopausal 
Tumor Status 30% Stage0/I    43% Stage II    27% Stage III 
Hormone Receptor Status 83% HR+ 
HER-2 Status 33% HER2+ 
Surgery 75% Lumpectomy 
Cancer Therapy 
67% Chemotherapy 
79% Radiation  
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Adherence Results 
Participant adherence is presented in Figure 1. 
 
Figure 1. Descriptive Statistics of Adherence to GR&H Program Protocol. The mean aerobic and resistance adherence 
was 72.5%±21.5%.  
The mean aerobic and resistance adherence was 72.5%  21.5% which was interpreted as 
non-adherent to the training prescription (criteria for acceptance was ≥80%). The minimum 
adherence was 31.3% and the maximum was 100%. The majority of participants (54.2%) 
were non-adherent to the training prescription but 45.8% were adherent, attending ≥39 days 
out of 48 possible days.  
 
Compliance Results 
Participant aerobic compliance is presented in Figure 2 and resistance compliance 
presented in Figure 3. 
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Figure 2. Descriptive Statistics of Aerobic Compliance to GR&H Program Protocol. The mean aerobic compliance 
was 23.6±9.6 days (49.1%±20.1%). 
The mean aerobic compliance was 23.69.6 days or 49.1%20.1%, which was interpreted 
as non-complaint to the aerobic training prescription. The minimum aerobic compliance 
was 6 days (12.5%) and the maximum was 42 days (87.5%). The majority of participants 
(95.8%) were non-compliant to the aerobic training prescription and 4.2% were compliant.  
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Figure 3. Descriptive Statistics of Resistance Compliance to GR&H Program Protocol. The mean resistance 
compliance was 12.5±4.8 days (26.0%±10.0%) 
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The mean resistance compliance was 12.54.8 days or 26.0%10.0%, which was 
interpreted as non-compliant to the resistance training prescription. The minimum 
resistance compliance was 4 days (8.3%) and the maximum was 29 days (60.4%). All 
participants (100%) were non-compliant to the resistance training prescription and 0% 
were compliant.  
 
Statistical Analysis Results 
Due to the unexpectedly small sample size representing compliant participants 
(n=1), neither our analysis examining change in VO2peak from pre to post testing among 
compliant participants nor Delta VO2peak between compliant and non-compliant 
participants was completed.  However, change in VO2peak from pre to post-test among all 
participants was explored and is presented in Table 2 below:  
Table 2. Participant VO2peak pre-test to post-test (n=24) 
 Pre Post Delta p-value 
VO2peak 
(mL/kg/min) 
21.2 ±5.8 22.1 ± 5.6 0.9 ± 3.2 0.178 
There was a non-significant increase in VO2peak (+0.9 mL/kg/min, p=0.178) from pre-test 
to post-test following the intervention. 
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Chapter V 
 
 
 
DISCUSSION 
This study examined adherence and compliance of breast cancer survivors to a 16-
week community-based, supervised, and progressive aerobic and resistance training 
program and evaluated the impact of intervention compliance on changes in VO2peak.  
Contrary to our hypotheses, the majority of patients (54.2%) were neither adherent 
to aerobic training nor resistance training based on the definition of adherence adopted in 
this study. Patients attained an average aerobic and resistance adherence of 72.5% 
(adherence set a priori at ≥80% prescribed days of training).  
The majority of patients (95.7%) were non-compliant to the aerobic training and all 
patients (100%) were non-compliant to the resistance training. Patients attained an average 
aerobic compliance of 49.1% and resistance compliance of 26.0% (compliance set a priori 
at ≥80%). Compliance was high until intensity progressed in week 5 of resistance training 
and week 8 of aerobic training.  
Meeting prescribed duration of aerobic training or prescribed sets/reps did not 
appear to be a factor limiting patient aerobic and resistance compliance. Patients often 
exceeded the prescribed aerobic training duration. Low compliance was primarily 
attributed to participants exercising at intensities lower than the prescribed level of exertion 
and therefore not meeting compliance criteria. During the first 5 weeks of the intervention, 
patients were on average resistance compliant with both sets/reps and intensity. However, 
resistance compliance sharply declined in the following 11 weeks of the intervention in 
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which intensity increased from a light- to moderate-intensity (RPE 7-13) to a high-intensity 
(RPE of 14-15).   
Possible barriers to meeting the prescribed training intensity include: lack of 
interest, reluctance of patients to engage at higher intensities due to safety concerns or 
discomfort associated with more challenging exercise, or possibly reluctance of trainers to 
encourage patients to reach the prescribed higher intensity. However, a moderate- to high-
intensity exercise program is supported as both feasible and safe in breast cancer patients8-
9. It is more effective in minimizing decline in cardiorespiratory fitness and muscle 
strength, limiting fatigue, and facilitating return to work compared to low-intensity 
physical activity programs9-10.  
An additional barrier to compliance may be lack of patient familiarization with the 
Borg Scale used to evaluate their self-perceived exertion and intensity. In a community-
based program, such as GR&H, RPE is a more feasible measure of intensity compared to 
HR, especially in group settings. However, lack of patient familiarization may have 
resulted in an inaccurate capture of attained intensity. During pre-testing, patients complete 
a cardiopulmonary exercise test (CPET) to volitional exhaustion, with a maximal RPE 
usually reported between 15-17. It is unlikely any exercise at GR&H approached a similar 
maximal demand relative to the CPET, therefore patients’ perception of their intensity 
using the Borg Scale may be skewed relative to how they used it for the max test. This may 
have resulted in lower reported RPE values than truly attained. Post-intervention, patients 
were given feedback/satisfaction questionnaires which may help clarify barriers to exercise 
engagement. Further conversations with patients about exercise prescription safety and use 
 29 
of the Borg Scale prior to starting the intervention would likely help reduce these factors 
affecting compliance.  
Based on adherence, patients attended on average 2 of the 3 prescribed aerobic and 
resistance training sessions per week. An attendance of 2 sessions of aerobic and resistance 
training sessions per week, each approximately 1 hour, results in an average weekly activity 
duration of 120 minutes of low- to moderate-intensity exercise. Thus, patients did not meet 
the recommended weekly physical activity duration or intensity for breast cancer patients 
set by American College of Sports Medicine (150 minutes of moderate-intensity exercise 
or 75 minutes of vigorous-intensity exercise)7. While patients’ attendance of 2 sessions per 
week of resistance training did meet ACSM strength training guidelines (2 to 3 sessions 
per week targeting major muscle groups), intensity was observed to be low similar to 
aerobic sessions, especially following the first 5 weeks of training. Reasons for not 
reaching prescribed resistance compliance are likely to reflect the possibilities previously 
described.  
In examining the impact of the intervention on VO2peak from pre-test to post-test 
among all patients, there was a non-significant increase in VO2peak (+0.9 mL/kg/min, 
p=0.178). The exercise adherence and compliance criteria (≥80%) was deemed a priori as 
a stimulus strong enough to impact aerobic capacity. Participants failed to reach this 
stimulus threshold, therefore the lack of improvement in VO2peak is congruent with their 
participation in the intervention. It is likely that better compliance in both resistance and 
aerobic exercise training would have provided a stronger stimulus capable of significantly 
improving VO2peak. However, while VO2peak did not significantly improve, it was 
maintained which is important in a population known to lose aerobic capacity following 
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treatment5. Therefore, even with poor aerobic compliance (49.1%) and resistance 
compliance (26.0%), both >30% below the set compliance threshold, the stimulus was 
beneficial in preventing potentially significant losses in aerobic capacity.   
Unexpectedly, 4 of the 23 non-compliant patients improved VO2peak on average 6.1 
mL/kg/min. These 4 patients had an average aerobic compliance of 49.5% and resistance 
compliance of 26.6% but still achieved a clinically significant (>2.8 mL/kg/min) increase 
in VO2peak.  It is possible that these patients were particularly aerobically compromised 
relative to others immediately following treatment, and their substantial improvements in 
aerobic capacity may be attributed to increased time since treatment completion (recovery) 
in combination with a gentle exercise stimulus. 
Our study’s strengths include full reporting of all exercise components of patient 
adherence and compliance and how those components were defined and calculated. This 
improves future study design and replication and has been recently determined as a lacking 
aspect of exercise oncology intervention trials14. However, significant limitations of our 
trial include small sample size and lack of participant compliance which prevented 
evaluating the impact of a community-based program on changes in aerobic capacity.  
 
Summary   
Our study fully reported patient adherence and compliance details regarding 
aerobic and resistance training components of a 16-week community-based exercise 
intervention. This provides future studies the ability to replicate analyses in a similar 
fashion and therefore enhance the ability to compare results and interventions between 
trials. While our intervention did not elicit statistically significant changes in VO2peak as 
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found in a previous study examining combined aerobic and resistance exercise 
prescriptions, our intervention adherence of 72.5% was similar to the previous study’s 
adherence of 70.2%6. However, compliance was not described in the previous study but 
may have been superior than what was observed in our study due to their results 
demonstrating a significant increase in VO2peak
6. Our findings of cardiorespiratory fitness 
maintenance following low compliance to combined aerobic and resistance exercise 
intervention is consistent with previous study findings5-6, 9-10 and is important because it 
suggests a minimal engagement in exercise may have worthwhile benefits for breast cancer 
survivors. Our results also provided a scope of understanding of patient participation in a 
community-based program and opportunities for restructuring to improve compliance for 
improved outcomes should be explored. Our findings may help improve future research 
study design and optimize training operation of a community-based program.  
 
Recommendations for Future Research 
Following poor patient adherence and compliance highlighted above, we suggest 
examination of barriers to adherence and compliance in a community-based exercise 
program. Poor compliance was primarily attributed to lack of exercise completion at 
prescribed higher intensities. Possible barriers to compliance include: lack of interest, or 
concern with safety of higher intensity exercise among patients, reluctance of trainers to 
encourage patients to engage in higher intensities or lack of familiarization with Borg Scale 
used to measure and capture intensity. Feedback questionnaires were given to patients post-
intervention, which may help measure these barriers. Further education on intervention 
safety and the Borg Scale would likely help reduce these factors affecting compliance. 
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Due to the small sample size of compliant patients (n=1), changes in VO2peak 
following aerobic and resistance compliance were not able to be statistically examined. We 
suggest efforts to increase the sample size, especially of complaint patients, and examine 
if a statistically significant change in VO2peak occurs following improved adherence and 
compliance to aerobic and resistance training.  
 
Conclusion 
In conclusion, patients enrolled in the 16-week program presented poor adherence 
and compliance potentially influencing the non-significant changes in VO2peak. However, 
low levels of compliance still provided maintenance in VO2peak in early stage breast cancer 
survivors who completed their major cancer treatments within 1-year. These findings lead 
us to believe even with low compliance maintenance of cardiorespiratory fitness appears 
possible and is still of considerable benefit in a compromised population known to 
demonstrate losses in aerobic capacity following cancer therapy.  
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